Brevan Howard Capital Management LP Catalent, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Catalent, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 36,297 shares of CTLT stock, worth $2.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
36,297Holding current value
$2.3 Million% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding CTLT
# of Institutions
484Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$473 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$406 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...